Biosyntia is a biotech startup within synthetic biology and metabolic engineering.
Biosyntia has raised $11.7M in total funding. The most recent round was Series B. The last funding was announced in July 2022.
Biosyntia's investors include Novo Holdings, Sofinnova Partners, European Circular Bioeconomy Fund, Novo Ventures.
Biosyntia is headquartered in Hørsholm, Denmark.
Biosyntia is a biotech startup within synthetic biology and metabolic engineering.
Biosyntia is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biosyntia — Funding & Investors." VCBacked, July 6, 2022, https://www.vcbacked.co/company/biosyntia. Accessed October 6, 2026.
VCBacked. (2022). Biosyntia — Funding & Investors. Retrieved October 6, 2026, from https://www.vcbacked.co/company/biosyntia
{{cite web |title=Biosyntia — Funding & Investors |url=https://www.vcbacked.co/company/biosyntia |website=VCBacked |access-date=October 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated